Techno Medica Co., Ltd. (TYO:6678)
Japan · Delayed Price · Currency is JPY 2,278.00
-33.00 (-1.43%)
Jan 23, 2026, 3:30 PM JST
Techno Medica Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 9,893 | 9,905 | 10,283 | 9,367 | 9,699 | 9,040 | Upgrade | |
Revenue Growth (YoY) | -4.35% | -3.68% | 9.78% | -3.42% | 7.29% | -7.85% | Upgrade |
Cost of Revenue | 5,086 | 4,978 | 5,131 | 4,738 | 4,882 | 4,586 | Upgrade |
Gross Profit | 4,807 | 4,927 | 5,152 | 4,629 | 4,817 | 4,454 | Upgrade |
Selling, General & Admin | 2,803 | 2,886 | 2,747 | 2,573 | 2,516 | 2,382 | Upgrade |
Research & Development | 690 | 690 | 516 | 369 | 405 | 433 | Upgrade |
Operating Expenses | 3,544 | 3,627 | 3,312 | 2,980 | 2,980 | 2,846 | Upgrade |
Operating Income | 1,263 | 1,300 | 1,840 | 1,649 | 1,837 | 1,608 | Upgrade |
Interest & Investment Income | 14 | 6 | - | 1 | 2 | 1 | Upgrade |
Currency Exchange Gain (Loss) | 7 | -15 | 2 | - | 6 | 4 | Upgrade |
Other Non Operating Income (Expenses) | 16 | 12 | 27 | 17 | 5 | 17 | Upgrade |
EBT Excluding Unusual Items | 1,300 | 1,303 | 1,869 | 1,667 | 1,850 | 1,630 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -9 | - | - | - | Upgrade |
Asset Writedown | - | - | - | -2 | - | - | Upgrade |
Other Unusual Items | 16 | 16 | - | - | - | 19 | Upgrade |
Pretax Income | 1,316 | 1,319 | 1,860 | 1,665 | 1,850 | 1,649 | Upgrade |
Income Tax Expense | 330 | 315 | 512 | 515 | 569 | 496 | Upgrade |
Net Income | 986 | 1,004 | 1,348 | 1,150 | 1,281 | 1,153 | Upgrade |
Net Income to Common | 986 | 1,004 | 1,348 | 1,150 | 1,281 | 1,153 | Upgrade |
Net Income Growth | -17.35% | -25.52% | 17.22% | -10.23% | 11.10% | 15.30% | Upgrade |
Shares Outstanding (Basic) | 7 | 7 | 8 | 8 | 8 | 8 | Upgrade |
Shares Outstanding (Diluted) | 7 | 7 | 8 | 8 | 8 | 8 | Upgrade |
Shares Change (YoY) | -3.38% | -11.17% | -7.64% | -0.64% | 0.01% | 0.04% | Upgrade |
EPS (Basic) | 142.29 | 144.99 | 172.93 | 136.26 | 150.81 | 135.75 | Upgrade |
EPS (Diluted) | 142.29 | 144.99 | 172.93 | 136.26 | 150.81 | 135.75 | Upgrade |
EPS Growth | -14.46% | -16.16% | 26.92% | -9.65% | 11.09% | 15.25% | Upgrade |
Free Cash Flow | -242 | 952 | 1,105 | 754 | 1,996 | 795 | Upgrade |
Free Cash Flow Per Share | -34.92 | 137.48 | 141.76 | 89.34 | 234.98 | 93.60 | Upgrade |
Gross Margin | 48.59% | 49.74% | 50.10% | 49.42% | 49.66% | 49.27% | Upgrade |
Operating Margin | 12.77% | 13.13% | 17.89% | 17.60% | 18.94% | 17.79% | Upgrade |
Profit Margin | 9.97% | 10.14% | 13.11% | 12.28% | 13.21% | 12.75% | Upgrade |
Free Cash Flow Margin | -2.45% | 9.61% | 10.75% | 8.05% | 20.58% | 8.79% | Upgrade |
EBITDA | 1,360 | 1,399 | 1,952 | 1,757 | 1,957 | 1,728 | Upgrade |
EBITDA Margin | 13.75% | 14.12% | 18.98% | 18.76% | 20.18% | 19.11% | Upgrade |
D&A For EBITDA | 97 | 99 | 112 | 108 | 120 | 120 | Upgrade |
EBIT | 1,263 | 1,300 | 1,840 | 1,649 | 1,837 | 1,608 | Upgrade |
EBIT Margin | 12.77% | 13.13% | 17.89% | 17.60% | 18.94% | 17.79% | Upgrade |
Effective Tax Rate | 25.08% | 23.88% | 27.53% | 30.93% | 30.76% | 30.08% | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.